Cargando…

Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy

Anti-epidermal-growth-factor-receptor (EGFR) monoclonal antibodies (mAbs) are of great significance for RAS and BRAF wild-type metastatic colorectal cancer (mCRC) patients. However, the generation of primary and secondary resistance to anti-EGFR mAbs has become an important factor restricting its ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shanshan, Hu, Wenwei, Feng, Jun, Geng, Yiting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490904/ https://www.ncbi.nlm.nih.gov/pubmed/36131281 http://dx.doi.org/10.1186/s12964-022-00960-x

Ejemplares similares

Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer
por: Chu, Jinjin, et al.
Publicado: (2022)

Emerging Role of Noncoding RNAs in EGFR TKI-Resistant Lung Cancer
por: Li, Jingwei, et al.
Publicado: (2022)

Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
por: Zhao, Ben, et al.
Publicado: (2016)

Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis
por: Geng, Yiting, et al.
Publicado: (2022)

Two cases of lymphangitic carcinomatosis as the primary symptom of colorectal carcinoma that achieved complete remission using combination anti-EGFR antibody therapy
por: Toshima, Hirokazu, et al.
Publicado: (2019)

Panning for Long Noncoding RNAs
por: Zhu, Shanshan, et al.
Publicado: (2013)

Noncoding RNAs in cancer therapy resistance and targeted drug development
por: Wang, Wen-Tao, et al.
Publicado: (2019)

Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
por: Li, Qing-Hai, et al.
Publicado: (2020)

Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies
por: Zhou, Jing, et al.
Publicado: (2021)

Comprehensive identification of long noncoding RNAs in colorectal cancer
por: James de Bony, Eric, et al.
Publicado: (2018)

Roles of long noncoding RNAs in colorectal cancer metastasis
por: Li, He, et al.
Publicado: (2017)

The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
por: Liao, Wenwei, et al.
Publicado: (2022)

Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
por: Takeiwa, Toshihiko, et al.
Publicado: (2020)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
por: Zottel, Alja, et al.
Publicado: (2020)

Long Noncoding RNAs: Emerging Biomarkers of Therapy Resistance and Tumor Progression
por: Deshpande, Ravindra P.
Publicado: (2023)

Comprehensive Analysis of Therapy-Related Messenger RNAs and Long Noncoding RNAs as Novel Biomarkers for Advanced Colorectal Cancer
por: Li, Jibin, et al.
Publicado: (2019)

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models
por: Vangala, Deepak, et al.
Publicado: (2021)

Long Noncoding RNAs in the Pathogenesis of Insulin Resistance
por: Yang, Weili, et al.
Publicado: (2022)

Noncoding RNAs
por: Hardikar, Anandwardhan A., et al.
Publicado: (2012)

Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer
por: Di Fiore, F, et al.
Publicado: (2010)

Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer
por: Sun, Weihong, et al.
Publicado: (2021)

Long noncoding RNAs in hematopoiesis
por: Zhang, Xu, et al.
Publicado: (2016)

Noncoding RNAs and Stem Cell Function and Therapy
por: Tang, Yaoliang, et al.
Publicado: (2018)

MicroRNAs, long noncoding RNAs, and circular RNAs: potential tumor biomarkers and targets for colorectal cancer
por: Yang, Shuaixi, et al.
Publicado: (2018)

Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer
por: Ciardiello, Davide, et al.
Publicado: (2021)

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
por: Liu, X., et al.
Publicado: (2015)

Decoding Noncoding RNAs: Role of MicroRNAs and Long Noncoding RNAs in Ocular Neovascularization
por: Zhang, Yan, et al.
Publicado: (2017)

Long Noncoding RNA LINC01485 Promotes Tumor Growth and Migration via Inhibiting EGFR Ubiquitination and Activating EGFR/Akt Signaling in Gastric Cancer
por: Zhou, Jianping, et al.
Publicado: (2020)

Long Noncoding RNAs Serve as Potential Diagnostic Biomarkers for Colorectal Cancer
por: Cai, Juan, et al.
Publicado: (2019)

Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs
por: Lizarbe, María Antonia, et al.
Publicado: (2017)

Noncoding RNAs in gastric cancer: implications for drug resistance
por: Wei, Ling, et al.
Publicado: (2020)

Noncoding RNAs Associated with Therapeutic Resistance in Pancreatic Cancer
por: Son, Seung Wan, et al.
Publicado: (2021)

Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
por: Li, Jiehan, et al.
Publicado: (2022)

Long Noncoding RNAs in Taxane Resistance of Breast Cancer
por: Chen, Hailong, et al.
Publicado: (2023)

Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer
por: Woolston, Andrew, et al.
Publicado: (2021)

Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer
por: Woolston, Andrew, et al.
Publicado: (2019)

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer
por: Ålgars, A, et al.
Publicado: (2011)

Comparative analysis of long noncoding RNAs in angiosperms and characterization of long noncoding RNAs in response to heat stress in Chinese cabbage
por: Song, Xiaoming, et al.
Publicado: (2021)

Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy
por: Ålgars, Annika, et al.
Publicado: (2014)

Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
por: Knickelbein, Kyle, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ep8loutkv3ddf59v0nuocb92vt